Department of Cardiology, Isala Hospital, Dr. Van Heesweg 2, 8025 AB, Zwolle, The Netherlands.
Regional Ambulance Service IJsselland, Zwolle, The Netherlands.
Appl Health Econ Health Policy. 2019 Dec;17(6):875-882. doi: 10.1007/s40258-019-00502-6.
There is increasing evidence that in patients presenting with acute chest pain, pre-hospital triage can accurately identify low-risk patients. It is, however, still unclear which diagnostics are performed in pre-hospital-adjudicated low-risk patients and what the contribution is of those diagnostic results in the healthcare process.
The aim of this study was to quantify healthcare utilization, costs, and outcomes in pre-hospital-adjudicated low-risk chest-pain patients, and to extrapolate to total costs in the Netherlands.
This was a prospective cohort study including 700 patients with suspected non-ST-elevation acute coronary syndrome in which pre-hospital risk stratification using the HEART score was performed by paramedics. Low risk was defined as a pre-hospital HEART score ≤ 3. Data on (results of) hospital diagnostics, costs, and discharge diagnosis were collected.
A total of 172 (25%) patients were considered as low risk. Of these low-risk patients, the mean age was 54 years, 52% were male, and 84% of patients were discharged within 12 h. Repeated electrocardiography and routine laboratory measurements, including cardiac markers, were performed in all patients. Chest X-ray was performed in 61% and echocardiography in 11% of patients. After additional diagnostics, two patients (1.2%) were diagnosed as non-ST-elevation myocardial infarction and two patients (1.2%) as unstable angina. Other diagnoses were atrial fibrillation (n = 1) and acute pancreatitis/cholecystitis (n = 2); all other patients had non-specific/non-acute discharge diagnoses. Mean in-hospital costs per patient were €1580. The estimated yearly acute healthcare cost in low-risk chest-pain patients in the Netherlands is €30,438,700.
In low-risk chest-pain patients according to pre-hospital risk assessment, acute healthcare utilization and costs are high, with limited added value. Possibly, if a complete risk assessment can be performed by ambulance paramedics, acute hospitalization of the majority of low-risk patients is not necessary, which can lead to substantial cost reduction.
Dutch Trial Register [http://www.trialregister.nl]: trial number 4205.
越来越多的证据表明,在出现急性胸痛的患者中,院前分诊可以准确识别低危患者。然而,目前仍不清楚在院前判定为低危的患者中进行了哪些诊断,以及这些诊断结果在医疗过程中的贡献是什么。
本研究的目的是量化院前判定为低危胸痛患者的医疗保健利用、成本和结局,并推断出荷兰的总费用。
这是一项前瞻性队列研究,纳入了 700 例疑似非 ST 段抬高型急性冠状动脉综合征患者,由护理人员使用 HEART 评分进行院前风险分层。低危定义为院前 HEART 评分≤3。收集了医院诊断、成本和出院诊断的数据。
共有 172 例(25%)患者被认为是低危。这些低危患者的平均年龄为 54 岁,52%为男性,84%的患者在 12 小时内出院。所有患者均进行了重复心电图和常规实验室检查,包括心脏标志物。61%的患者进行了胸部 X 光检查,11%的患者进行了超声心动图检查。在进行了额外的诊断后,有 2 例(1.2%)患者被诊断为非 ST 段抬高型心肌梗死,2 例(1.2%)患者被诊断为不稳定型心绞痛。其他诊断包括心房颤动(n=1)和急性胰腺炎/胆囊炎(n=2);所有其他患者均为非特异性/非急性出院诊断。每位患者的平均住院费用为 1580 欧元。荷兰低危胸痛患者的急性医疗保健年度费用估计为 30438700 欧元。
根据院前风险评估,低危胸痛患者的急性医疗保健利用和成本较高,但增值有限。如果可以由救护车护理人员进行全面的风险评估,可能不需要对大多数低危患者进行急性住院治疗,从而可以显著降低成本。
荷兰试验注册处[http://www.trialregister.nl]:试验编号 4205。